--(BUSINESS WIRE)--A leading contract research organization (CRO) dedicated to
ophthalmology, Iris Pharma helps clients around the world navigate every
stage of the drug and device development process – including in vivo
screening, proof of concept, ocular efficacy, GLP preclinical studies,
bioanalysis, clinical trials, and marketing surveys.
We have
partnered with clients to bring nearly 50 ocular drugs and medical
devices to market in the past 25 years, in addition to offering
consulting services to help clients determine the best indication for
molecules and products in development. Our expertise covers all
ophthalmic indications, and we support clients ranging from small
start-ups to large pharmaceutical companies in moving forward products
that directly or indirectly affect eye health.
Visit us online at www.iris-pharma.com.
|
Company: |
Iris Pharma, An Ophthalmology-focused CRO | |
|
Headquarters Address: |
Allée Hector Pintus | |
| La Gaude 06610 | ||
| France | ||
|
Main Telephone: |
33493594959 | |
|
Website: |
||
|
Type of Organization: |
Private | |
|
Industry: |
Research & Science | |
|
Key Executives: |
CEO: Pierre-Paul Elena |
|
|
Public Relations |
||
|
Contact: |
Katia de Cuyper Barcaroli | |
|
Phone: |
33493594959 | |
|
Email: |
||
|
Customer Service |
||
|
Contact: |
Sophie Chiabaut | |
|
Phone: |
33493594959 | |
|
Email: |
